ENLV (ENLV) Stock Price & Analysis
ENLV (ENLV) fell 5.17% to USD 1.1 as of September 8, 2026 at 09:03 UTC, according to Nexqual real-time market data.
ENLV last closed at USD 1.1; the session ranged USD 1.02–1.15 on volume of 252,141 shares. Market capitalization is —, with a 52-week range of USD 1.02–27.15 (NCM). Source: Nexqual, September 8, 2026 at 09:03 UTC.
Key Statistics (as of September 8, 2026 at 09:03 UTC)
| Price | USD 1.1 |
|---|---|
| Change | ▼ 5.17% (down) |
| Previous Close | USD 1.1 |
| Open | USD 1.1 |
| Day Range | USD 1.02 – 1.15 |
| 52-Week Range | USD 1.02 – 27.15 |
| Volume | 252,141 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (ENLV)
Nexqual's technical model rates ENLV "SELL" based on 2 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 09:03 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 14 (oversold) |
| vs SMA50 | Below (USD 3.64) |
| MACD | -0.67 (negative) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| KMDA | Kamada Ltd. | USD 8.54 | ▲ 1.67% |
| EVGN | Evogene Ltd. | USD 0.54 | ▼ 0.37% |
| ENTX | Entera Bio Ltd. | USD 3 | ▲ 2.74% |
| EDSA | Edesa Biotech, Inc. | USD 4.73 | ▼ 0.63% |
| RDHL | Redhill Biopharma Ltd. | USD 0.72 | ▼ 2.24% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 09:03 UTC. This page is informational and not investment advice.